Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

Clinical trial NCT00102752 · COMPLETED

Trial details

NCT number: NCT00102752
Sponsor: Threshold Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms Pancreatic Neoplasms

Start date: 2004-12-01
Primary completion: 2007-07-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.